Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen concentrate for on-demand treatment of acute bleeding in congenital fibrinogen deficiency
2007-004088-22Phase 3Terminated
- Sponsor
- CSL Behring
- Start
- Nov 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Fibrinogen human in fibrinogen deficiency, sponsored by CSL Behring. Primary endpoint: Bleeding requiring intervention. Started Nov 2009; status: terminated.
02
Drugs
Fibrinogen human
03
Conditions
fibrinogen deficiency
Beyond the preview
Go deeper on 2007-004088-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004088-22.